ACAD Acadia Pharmaceuticals Inc. Loading...

From OMC earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
20:30
Apr 28 ◎
John Wren Chairman and Chief Executive Officer, Omnicom Group Inc. OMC Q1 FY26 call
Winning Acadia Pharmaceuticals as a new client indicates a significant marketing win in the pharma sector.
ACAD
HIGH

About ACAD Analyst Coverage

Buzzberg tracks ACAD (Acadia Pharmaceuticals Inc.) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Latest voices: John Wren.